Company MEDINET Co., Ltd.

Equities

2370

JP3920990003

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Other Biotechnology & Medical Research

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-07-08 am EDT			5-day change	1st Jan Change
44 ^JPY	0.00%		-2.22%	+2.33%

2023	MEDINET Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending September 30, 2024	CI
2023	Kokoro Mill Co., Ltd announced that it has received ¥270 million in funding from MEDINET Co., Ltd., Macnica, Inc., Nahato Inc. and other investors.	CI

MEDINET Co., Ltd. is a Japan-based company mainly engaged in cell processing industry and cellular medical products business. It operates through two business segments. The Cell Processing Industry segment mainly engages in comprehensive support services for immune cell therapy, related services including clinical use from companies, universities, research institutes, outsourcing of cell processing for clinical trials and operation of cell culture processing facilities. The Cellular Medical Products segment is mainly engaged in research and development for obtaining approval for manufacture and marketing of cellular medical products. It also provides comprehensive support services for immune cell therapy.

Number of employees: 92

JPY in Million	2022	Weight	2023	Weight	Delta
Cell Processing 99.9 %	633	100.0 %	661	99.9 %	+4.36%
Regenerative Medicine Product 0.1 %	0	0.0 %	0	0.1 %	+111.31%

JPY in Million	2022	Weight	2023	Weight	Delta
Japan 100.0 %	634	100.0 %	662	100.0 %	+4.40%

Managers	Title	Age	Since
Yoshiji Kimura FOU	Founder	72	95-10-16
Kanenao Kubushiro PSD	President	64	20-11-30
Masazo Ochiai ADM	Chief Administrative Officer	49	04-08-31
Takashige Kondo BRD	Director/Board Member	49	03-03-31

Members of the board	Title	Age	Since
Yoshiji Kimura FOU	Founder	72	95-10-16
Kohichiro Yoshino BRD	Director/Board Member	75	18-11-30
Takeshi Shinoda BRD	Director/Board Member	62	14-09-30
Masazo Ochiai ADM	Chief Administrative Officer	49	04-08-31
Takashige Kondo BRD	Director/Board Member	49	03-03-31
Kanenao Kubushiro PSD	President	64	20-11-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	256,490,306	239,235,220 ( 93.27 %)	64 ( 0.000025 %)	93.27 %

Name	Equities	%	Valuation
Yoshiji Kimura 3.027 %	7,764,167	3.027 %	2 M ¥
Sansei Juhatsu KK 0.8187 %	2,100,000	0.8187 %	587 475 ¥
Kanehiro Moribe 0.5458 %	1,400,000	0.5458 %	391 650 ¥
Masami Nakano 0.4289 %	1,100,000	0.4289 %	307 725 ¥
Land Carry Co. Ltd. 0.3918 %	1,005,000	0.3918 %	281 149 ¥
Yasunori Igari 0.3899 %	1,000,000	0.3899 %	279 750 ¥
KANEKA CORPORATION 0.1560 %	400,000	0.1560 %	111 900 ¥
Medinet Restricted Stock Compensation Plan 0.0411 %	105,334	0.0411 %	29 467 ¥

MEDINET Co., Ltd.

TRC Center Building, 9/F 6-1-1 Heiwajima

143-0006, Tokyo

http://www.medinet-inc.co.jp

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
MEDINET CO., LTD.	+2.33%	70.23M
MODERNA, INC.	+17.09%	45.34B
LONZA GROUP AG	+42.10%	40.42B
IQVIA HOLDINGS INC.	-9.70%	37.92B
ALNYLAM PHARMACEUTICALS, INC.	+33.28%	31.75B
CELLTRION, INC.	-8.98%	27.71B
ICON PUBLIC LIMITED COMPANY	+13.37%	26.52B
UNITED THERAPEUTICS CORPORATION	+44.11%	13.96B
MEDPACE HOLDINGS, INC.	+32.33%	12.44B
BIO-TECHNE CORPORATION	-7.26%	11.26B

Other Biotechnology & Medical Research